Manchester Capital Management LLC Emergent Bio Solutions Inc. Transaction History
Manchester Capital Management LLC
- $802 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding EBS
# of Institutions
134Shares Held
35.6MCall Options Held
78.7KPut Options Held
75.1K-
Black Rock Inc. New York, NY7.06MShares$48.2 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA4.15MShares$28.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.41MShares$23.3 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.91MShares$13 Million0.19% of portfolio
-
Morgan Stanley New York, NY1.29MShares$8.82 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $340M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...